BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ji JY, Jo A, Won J, Gil CH, Shin H, Kim S, Jeon YJ, Kim HJ. The nasal symbiont Staphylococcus species restricts the transcription of SARS-CoV-2 entry factors in human nasal epithelium. iScience 2021;24:103172. [PMID: 34604720 DOI: 10.1016/j.isci.2021.103172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Shin H, Kim S, Jo A, Won J, Gil CH, Yoon SY, Cha H, Kim HJ. Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. Front Immunol 2022;13:1009424. [PMID: 36524125 DOI: 10.3389/fimmu.2022.1009424] [Reference Citation Analysis]
2 Kao M, Yang J, Balasubramaniam A, Traisaeng S, Jackson Yang A, Yang JJ, Salamon BP, Herr DR, Huang C. Colonization of nasal cavities by Staphylococcus epidermidis mitigates SARS‐CoV‐2 nucleocapsid phosphoprotein‐induced interleukin (IL)‐6 in the lung. Microbial Biotechnology. [DOI: 10.1111/1751-7915.13994] [Reference Citation Analysis]
3 Ortega-peña S, Rodríguez-martínez S, Cancino-diaz ME, Cancino-diaz JC. Staphylococcus epidermidis Controls Opportunistic Pathogens in the Nose, Could It Help to Regulate SARS-CoV-2 (COVID-19) Infection? Life 2022;12:341. [DOI: 10.3390/life12030341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]